スパイロメーター市場の2030年までの予測：製品別、技術別、用途別、エンドユーザー別、地域別の世界分析

Stratistics MRCによると、世界のスパイロメーター市場は2023年に11億5,520万米ドルを占め、2030年には27億3,630万米ドルに達すると予測され、予測期間中のCAGRは13.1％です。

スパイロメーターは、吸気または呼気の量を評価することによって肺機能を測定するために使用される医療機器です。これらの機器は、肺活量、気流、呼吸筋の効率などの重要な呼吸パラメータを測定します。呼吸操作中の空気の量と移動速度を分析することにより、スパイロメーターは、喘息、慢性閉塞性肺疾患（COPD）、その他の呼吸器疾患の診断やモニタリング、治療の指導、肺機能の評価に役立ちます。

国立心肺血液研究所が2022年3月に発表した論文によると、COPDは米国における死亡原因の第1位であり、約1,600万人の米国人が罹患しています。

成長促進要因：呼吸器疾患の増加

喘息、COPD、肺線維症のような呼吸器疾患の有病率が世界的に増加しているため、肺機能を評価する診断ツールの需要が高まっています。スパイロメーターは、これらの疾患の診断、疾患進行のモニタリング、治療効果の評価において極めて重要な役割を果たしています。呼吸器疾患の早期発見と管理が重視されるようになり、スパイロメトリー装置の需要は伸び続けており、ヘルスケアニーズの高まりに対応するための市場拡大が推進されています。

成長抑制要因：認知度と入手性の欠如

特定の地域やヘルスケア環境では、呼吸器健康評価の重要性やスパイロメトリー検査の利点に関する認識が不十分です。さらに、ヘルスケア施設へのアクセスに格差があるため、遠隔地や十分なサービスを受けていない地域でのスパイロメータの利用が制限されています。ヘルスケア専門家のトレーニングが不十分であることも、導入の妨げとなっています。このような認識不足と限られたアクセシビリティが、スパイロメトリーツールの普及を妨げ、その使用を制約し、市場成長に影響を与えています。

機会：在宅ヘルスケア志向の高まり

在宅ヘルスケア志向の高まりは、スパイロメーター市場に好機をもたらします。患者が簡便なモニタリングオプションを求める中、ポータブルスパイロメーターは、家庭環境での呼吸評価を可能にすることで、この動向に対応しています。これらの装置により、慢性呼吸器疾患の患者は定期的に肺機能をモニターすることができ、タイムリーな介入が容易になり、病院への受診が減少します。さらに、在宅ケアへのシフトは、独立性と利便性を求める患者の嗜好と一致し、ポータブル・スパイロメトリーソリューションの需要を促進し、従来のヘルスケア施設以外でもアクセス可能な呼吸モニタリングオプションを提供することで市場を拡大します。

脅威：データプライバシーとセキュリティへの懸念

スパイロメトリー装置がデータの保存と分析のためにデジタルシステムと接続され統合される場合、潜在的な侵害、不正アクセス、データの悪用のリスクが高まる。スパイロメトリー検査中に収集される患者の健康情報は、機密性を確保するために保護が必要です。このような懸念に対処しないと、患者の信頼が損なわれ、導入が妨げられ、規制当局の監視を受けることになります。

COVID-19の影響

COVID-19の流行中、スパイロメーターは課題と適応に直面しました。当初、スパイロメトリー検査中のエアロゾル発生に関する懸念が生じ、感染リスクのためにその使用に影響が生じた。しかし、理解が進むにつれて、特に重要な呼吸器評価のための安全なスパイロメトリー実施を確保するためのプロトコルが確立されました。さらに、パンデミックは遠隔モニタリングと遠隔医療ソリューションの開発を加速し、スパイロメーターをバーチャルヘルスケアセットアップに統合することを促進しました。

予測期間中、流量測定セグメントが最大となる見込み

予測期間中、呼吸機能の評価における基本的な役割から、流量測定セグメントがスパイロメーター市場を独占すると予測されます。流量測定は、吸気および呼気中の空気の移動速度に関する重要なデータを提供し、呼吸器疾患の診断およびモニタリングに役立ちます。さらに、流量測定の精度と感度は正確な呼吸評価に大きく貢献するため、スパイロメーター市場における同分野の優位性を予想する主要な促進要因となっています。

予測期間中、病院セグメントのCAGRが最も高くなる見込み

予測期間中、病院セグメントは大きな成長を遂げると思われます。病院は、呼吸器の診断と治療を含む包括的なヘルスケアサービスの主要なセンターであり続けています。呼吸器疾患の罹患率の上昇に伴い、高度なスパイロメトリー装置に対する病院の需要は高まっています。さらに、呼吸器疾患の早期発見と管理への注目の高まりが、病院環境における正確な診断ツールの必要性を高めています。さらに、技術の進歩と病院情報システムへのスパイロメータの統合が、このセグメントの成長をさらに促進しています。

最大のシェアを占める地域

北米は、先進的なヘルスケアインフラ、高い医療費、呼吸器系の健康への強い関心により、スパイロメーター市場で最大の市場シェアを確保します。さらに、認知度の向上、有利な償還政策、スパイロメトリー装置の技術的進歩が市場の成長に寄与しています。さらに、北米では呼吸器疾患の有病率が高く、ヘルスケア革新に積極的に取り組んでいることから、同地域はスパイロメトリーソリューションの採用と導入で大きなシェアを占め、主要市場のリーダーとして位置づけられています。

CAGRが最も高い地域

アジア太平洋地域は、呼吸器疾患の有病率の上昇と高齢者人口の増加により、スパイロメーター市場で力強い成長を記録する見込みです。さらに、ヘルスケア支出の増加、医療インフラの改善、呼吸器の健康に関する意識の高まりが市場をさらに牽引しています。さらに、技術の進歩、ポータブルで手頃な価格のスパイロメトリー装置の採用、農村部へのヘルスケアアクセスの拡大が、アジア太平洋地域における市場の成長を促進しています。

無料のカスタマイズ提供

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかを提供させていただきます。

• 企業プロファイル
  • 追加市場企業の包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査ソース
  • 1次調査ソース
  • 2次調査ソース
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• 技術分析
• 用途分析
• エンドユーザー分析
• 新興市場
• 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 企業間の競合関係

第5章 世界のスパイロメーター市場：製品別

• デバイス
  • デスクトップ型スパイロメーター
  • 手持ち型スパイロメーター
  • 卓上型スパイロメーター
• ソフトウェア
• 消耗品と付属品

第6章 世界のスパイロメーター市場：技術別

• 体積測定
• 流量測定

第7章 世界のスパイロメーター市場：用途別

• 慢性閉塞性肺疾患（COPD）
• 喘息
• 嚢胞性線維症
• 肺線維症
• その他の用途

第8章 世界のスパイロメーター市場：エンドユーザー別

• 病院
• クリニック
• 在宅ケア

第9章 世界のスパイロメーター市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋地域
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋地域
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東とアフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東とアフリカ

第10章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品の発売
• 事業拡大
• その他の主要戦略

第11章 企業プロファイル

• Benson Medical Instruments
• Bionet America, Inc.
• CareFusion
• Cosmed Srl
• Fukuda Sangyo Co., Ltd.
• Future Med Devices Pvt. Ltd.
• Medikro Oy
• MGC Diagnostics Corporation
• Midmark Corporation
• Morgan Scientific Inc.
• NDD Medical Technologies
• Nihon Kohden Corporation
• Schiller AG
• SDI Diagnostics
• Vitalograph Ltd
• Welch Allyn, Inc.

List of Tables

• Table 1 Global Spirometers Market Outlook, By Region (2021-2030) ($MN)
• Table 2 Global Spirometers Market Outlook, By Product (2021-2030) ($MN)
• Table 3 Global Spirometers Market Outlook, By Devices (2021-2030) ($MN)
• Table 4 Global Spirometers Market Outlook, By Desktop Spirometer (2021-2030) ($MN)
• Table 5 Global Spirometers Market Outlook, By Hand Held Spirometer (2021-2030) ($MN)
• Table 6 Global Spirometers Market Outlook, By Table Top Spirometer (2021-2030) ($MN)
• Table 7 Global Spirometers Market Outlook, By Software (2021-2030) ($MN)
• Table 8 Global Spirometers Market Outlook, By Consumables & Accessories (2021-2030) ($MN)
• Table 9 Global Spirometers Market Outlook, By Technology (2021-2030) ($MN)
• Table 10 Global Spirometers Market Outlook, By Volume Measurement (2021-2030) ($MN)
• Table 11 Global Spirometers Market Outlook, By Flow Measurement (2021-2030) ($MN)
• Table 12 Global Spirometers Market Outlook, By Application (2021-2030) ($MN)
• Table 13 Global Spirometers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 14 Global Spirometers Market Outlook, By Asthma (2021-2030) ($MN)
• Table 15 Global Spirometers Market Outlook, By Cystic Fibrosis (2021-2030) ($MN)
• Table 16 Global Spirometers Market Outlook, By Pulmonary Fibrosis (2021-2030) ($MN)
• Table 17 Global Spirometers Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 18 Global Spirometers Market Outlook, By End User (2021-2030) ($MN)
• Table 19 Global Spirometers Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 20 Global Spirometers Market Outlook, By Clinics (2021-2030) ($MN)
• Table 21 Global Spirometers Market Outlook, By Homecare (2021-2030) ($MN)
• Table 22 North America Spirometers Market Outlook, By Country (2021-2030) ($MN)
• Table 23 North America Spirometers Market Outlook, By Product (2021-2030) ($MN)
• Table 24 North America Spirometers Market Outlook, By Devices (2021-2030) ($MN)
• Table 25 North America Spirometers Market Outlook, By Desktop Spirometer (2021-2030) ($MN)
• Table 26 North America Spirometers Market Outlook, By Hand Held Spirometer (2021-2030) ($MN)
• Table 27 North America Spirometers Market Outlook, By Table Top Spirometer (2021-2030) ($MN)
• Table 28 North America Spirometers Market Outlook, By Software (2021-2030) ($MN)
• Table 29 North America Spirometers Market Outlook, By Consumables & Accessories (2021-2030) ($MN)
• Table 30 North America Spirometers Market Outlook, By Technology (2021-2030) ($MN)
• Table 31 North America Spirometers Market Outlook, By Volume Measurement (2021-2030) ($MN)
• Table 32 North America Spirometers Market Outlook, By Flow Measurement (2021-2030) ($MN)
• Table 33 North America Spirometers Market Outlook, By Application (2021-2030) ($MN)
• Table 34 North America Spirometers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 35 North America Spirometers Market Outlook, By Asthma (2021-2030) ($MN)
• Table 36 North America Spirometers Market Outlook, By Cystic Fibrosis (2021-2030) ($MN)
• Table 37 North America Spirometers Market Outlook, By Pulmonary Fibrosis (2021-2030) ($MN)
• Table 38 North America Spirometers Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 39 North America Spirometers Market Outlook, By End User (2021-2030) ($MN)
• Table 40 North America Spirometers Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 41 North America Spirometers Market Outlook, By Clinics (2021-2030) ($MN)
• Table 42 North America Spirometers Market Outlook, By Homecare (2021-2030) ($MN)
• Table 43 Europe Spirometers Market Outlook, By Country (2021-2030) ($MN)
• Table 44 Europe Spirometers Market Outlook, By Product (2021-2030) ($MN)
• Table 45 Europe Spirometers Market Outlook, By Devices (2021-2030) ($MN)
• Table 46 Europe Spirometers Market Outlook, By Desktop Spirometer (2021-2030) ($MN)
• Table 47 Europe Spirometers Market Outlook, By Hand Held Spirometer (2021-2030) ($MN)
• Table 48 Europe Spirometers Market Outlook, By Table Top Spirometer (2021-2030) ($MN)
• Table 49 Europe Spirometers Market Outlook, By Software (2021-2030) ($MN)
• Table 50 Europe Spirometers Market Outlook, By Consumables & Accessories (2021-2030) ($MN)
• Table 51 Europe Spirometers Market Outlook, By Technology (2021-2030) ($MN)
• Table 52 Europe Spirometers Market Outlook, By Volume Measurement (2021-2030) ($MN)
• Table 53 Europe Spirometers Market Outlook, By Flow Measurement (2021-2030) ($MN)
• Table 54 Europe Spirometers Market Outlook, By Application (2021-2030) ($MN)
• Table 55 Europe Spirometers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 56 Europe Spirometers Market Outlook, By Asthma (2021-2030) ($MN)
• Table 57 Europe Spirometers Market Outlook, By Cystic Fibrosis (2021-2030) ($MN)
• Table 58 Europe Spirometers Market Outlook, By Pulmonary Fibrosis (2021-2030) ($MN)
• Table 59 Europe Spirometers Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 60 Europe Spirometers Market Outlook, By End User (2021-2030) ($MN)
• Table 61 Europe Spirometers Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 62 Europe Spirometers Market Outlook, By Clinics (2021-2030) ($MN)
• Table 63 Europe Spirometers Market Outlook, By Homecare (2021-2030) ($MN)
• Table 64 Asia Pacific Spirometers Market Outlook, By Country (2021-2030) ($MN)
• Table 65 Asia Pacific Spirometers Market Outlook, By Product (2021-2030) ($MN)
• Table 66 Asia Pacific Spirometers Market Outlook, By Devices (2021-2030) ($MN)
• Table 67 Asia Pacific Spirometers Market Outlook, By Desktop Spirometer (2021-2030) ($MN)
• Table 68 Asia Pacific Spirometers Market Outlook, By Hand Held Spirometer (2021-2030) ($MN)
• Table 69 Asia Pacific Spirometers Market Outlook, By Table Top Spirometer (2021-2030) ($MN)
• Table 70 Asia Pacific Spirometers Market Outlook, By Software (2021-2030) ($MN)
• Table 71 Asia Pacific Spirometers Market Outlook, By Consumables & Accessories (2021-2030) ($MN)
• Table 72 Asia Pacific Spirometers Market Outlook, By Technology (2021-2030) ($MN)
• Table 73 Asia Pacific Spirometers Market Outlook, By Volume Measurement (2021-2030) ($MN)
• Table 74 Asia Pacific Spirometers Market Outlook, By Flow Measurement (2021-2030) ($MN)
• Table 75 Asia Pacific Spirometers Market Outlook, By Application (2021-2030) ($MN)
• Table 76 Asia Pacific Spirometers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 77 Asia Pacific Spirometers Market Outlook, By Asthma (2021-2030) ($MN)
• Table 78 Asia Pacific Spirometers Market Outlook, By Cystic Fibrosis (2021-2030) ($MN)
• Table 79 Asia Pacific Spirometers Market Outlook, By Pulmonary Fibrosis (2021-2030) ($MN)
• Table 80 Asia Pacific Spirometers Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 81 Asia Pacific Spirometers Market Outlook, By End User (2021-2030) ($MN)
• Table 82 Asia Pacific Spirometers Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 83 Asia Pacific Spirometers Market Outlook, By Clinics (2021-2030) ($MN)
• Table 84 Asia Pacific Spirometers Market Outlook, By Homecare (2021-2030) ($MN)
• Table 85 South America Spirometers Market Outlook, By Country (2021-2030) ($MN)
• Table 86 South America Spirometers Market Outlook, By Product (2021-2030) ($MN)
• Table 87 South America Spirometers Market Outlook, By Devices (2021-2030) ($MN)
• Table 88 South America Spirometers Market Outlook, By Desktop Spirometer (2021-2030) ($MN)
• Table 89 South America Spirometers Market Outlook, By Hand Held Spirometer (2021-2030) ($MN)
• Table 90 South America Spirometers Market Outlook, By Table Top Spirometer (2021-2030) ($MN)
• Table 91 South America Spirometers Market Outlook, By Software (2021-2030) ($MN)
• Table 92 South America Spirometers Market Outlook, By Consumables & Accessories (2021-2030) ($MN)
• Table 93 South America Spirometers Market Outlook, By Technology (2021-2030) ($MN)
• Table 94 South America Spirometers Market Outlook, By Volume Measurement (2021-2030) ($MN)
• Table 95 South America Spirometers Market Outlook, By Flow Measurement (2021-2030) ($MN)
• Table 96 South America Spirometers Market Outlook, By Application (2021-2030) ($MN)
• Table 97 South America Spirometers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 98 South America Spirometers Market Outlook, By Asthma (2021-2030) ($MN)
• Table 99 South America Spirometers Market Outlook, By Cystic Fibrosis (2021-2030) ($MN)
• Table 100 South America Spirometers Market Outlook, By Pulmonary Fibrosis (2021-2030) ($MN)
• Table 101 South America Spirometers Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 102 South America Spirometers Market Outlook, By End User (2021-2030) ($MN)
• Table 103 South America Spirometers Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 104 South America Spirometers Market Outlook, By Clinics (2021-2030) ($MN)
• Table 105 South America Spirometers Market Outlook, By Homecare (2021-2030) ($MN)
• Table 106 Middle East & Africa Spirometers Market Outlook, By Country (2021-2030) ($MN)
• Table 107 Middle East & Africa Spirometers Market Outlook, By Product (2021-2030) ($MN)
• Table 108 Middle East & Africa Spirometers Market Outlook, By Devices (2021-2030) ($MN)
• Table 109 Middle East & Africa Spirometers Market Outlook, By Desktop Spirometer (2021-2030) ($MN)
• Table 110 Middle East & Africa Spirometers Market Outlook, By Hand Held Spirometer (2021-2030) ($MN)
• Table 111 Middle East & Africa Spirometers Market Outlook, By Table Top Spirometer (2021-2030) ($MN)
• Table 112 Middle East & Africa Spirometers Market Outlook, By Software (2021-2030) ($MN)
• Table 113 Middle East & Africa Spirometers Market Outlook, By Consumables & Accessories (2021-2030) ($MN)
• Table 114 Middle East & Africa Spirometers Market Outlook, By Technology (2021-2030) ($MN)
• Table 115 Middle East & Africa Spirometers Market Outlook, By Volume Measurement (2021-2030) ($MN)
• Table 116 Middle East & Africa Spirometers Market Outlook, By Flow Measurement (2021-2030) ($MN)
• Table 117 Middle East & Africa Spirometers Market Outlook, By Application (2021-2030) ($MN)
• Table 118 Middle East & Africa Spirometers Market Outlook, By Chronic Obstructive Pulmonary Disease (COPD) (2021-2030) ($MN)
• Table 119 Middle East & Africa Spirometers Market Outlook, By Asthma (2021-2030) ($MN)
• Table 120 Middle East & Africa Spirometers Market Outlook, By Cystic Fibrosis (2021-2030) ($MN)
• Table 121 Middle East & Africa Spirometers Market Outlook, By Pulmonary Fibrosis (2021-2030) ($MN)
• Table 122 Middle East & Africa Spirometers Market Outlook, By Other Applications (2021-2030) ($MN)
• Table 123 Middle East & Africa Spirometers Market Outlook, By End User (2021-2030) ($MN)
• Table 124 Middle East & Africa Spirometers Market Outlook, By Hospitals (2021-2030) ($MN)
• Table 125 Middle East & Africa Spirometers Market Outlook, By Clinics (2021-2030) ($MN)
• Table 126 Middle East & Africa Spirometers Market Outlook, By Homecare (2021-2030) ($MN)

According to Stratistics MRC, the Global Spirometers Market is accounted for $1155.2 million in 2023 and is expected to reach $2736.3 million by 2030 growing at a CAGR of 13.1% during the forecast period. Spirometers are medical devices used to measure lung function by assessing the volume of air inhaled or exhaled. These instruments gauge vital respiratory parameters, including lung capacity, airflow and the efficiency of respiratory muscles. By analyzing the volume and speed of air movement during breathing maneuvers, spirometers aid in diagnosing and monitoring conditions like asthma, chronic obstructive pulmonary disease (COPD) and other respiratory disorders, guiding treatment and evaluating pulmonary function.

According to an article published by the National Heart, Lung, and Blood Institute in March 2022, COPD is the leading cause of death in the U.S., affecting about 16 million Americans.

Market Dynamics:

Driver:

Rising incidence of respiratory diseases

Owing to the increasing prevalence of respiratory diseases like asthma, COPD, and pulmonary fibrosis worldwide, there's a heightened demand for diagnostic tools to assess lung function. Spirometers play a pivotal role in diagnosing these ailments, monitoring disease progression, and evaluating treatment efficacy. With a rising emphasis on early detection and management of respiratory disorders, the demand for spirometry devices continues to grow, driving market expansion to cater to the escalating healthcare needs.

Restraint:

Lack of awareness and availability

In certain regions or healthcare settings, there's inadequate awareness regarding the importance of respiratory health assessment and the benefits of spirometry testing. Additionally, disparities in access to healthcare facilities restrict the availability of spirometers in remote or underserved areas. Insufficient training among healthcare professionals further impedes adoption. This lack of awareness and limited accessibility hinders widespread adoption of spirometry tools, constraining their usage and impacting market growth.

Opportunity:

Growing preference for home healthcare

The increasing inclination towards home healthcare presents an opportunity in the spirometers market. As patients seek convenient monitoring options, portable spirometers cater to this trend by enabling respiratory assessments in home settings. These devices allow individuals with chronic respiratory conditions to regularly monitor lung function, facilitating timely intervention and reducing hospital visits. Moreover, the shift towards home-based care aligns with patient preferences for independence and convenience, driving the demand for portable spirometry solutions and expanding the market by offering accessible respiratory monitoring options outside traditional healthcare facilities.

Threat:

Data privacy and security concerns

When spirometry devices are connected and integrated with digital systems for data storage and analysis, there's a heightened risk of potential breaches, unauthorized access or data misuse. Patient health information collected during spirometry tests requires protection to ensure confidentiality. Failure to address these concerns can erode patient trust, hinder adoption, and lead to regulatory scrutiny.

COVID-19 Impact:

During the COVID-19 pandemic, spirometers faced challenges and adaptations. Initially, concerns arose regarding aerosol generation during spirometry tests, impacting their use due to infection risks. However, as understanding evolved, protocols were established to ensure safe spirometry practices, especially for essential respiratory assessments. Additionally, the pandemic accelerated the development of remote monitoring and telemedicine solutions, fostering the integration of spirometers into virtual healthcare setups, allowing continued respiratory monitoring and management while minimizing in-person contact and enhancing remote patient care.

The flow measurement segment is expected to be the largest during the forecast period

Over the forecast period, the flow measurement segment is anticipated to dominate the spirometers market, attributed to its fundamental role in assessing respiratory function. Flow measurements provide crucial data on the rate of air movement during inhalation and exhalation, aiding in the diagnosis and monitoring of respiratory conditions. Moreover, the precision and sensitivity of flow measurements contribute significantly to accurate respiratory assessments, making them a key driver for the segment's anticipated dominance in the spirometers market.

The hospitals segment is expected to have the highest CAGR during the forecast period

During the forecast period, the hospitals segment is poised to witness significant growth. Hospitals remain the primary centers for comprehensive healthcare services, including respiratory diagnostics and treatment. With a rising incidence of respiratory ailments, hospitals demand for advanced spirometry equipment is escalating. Additionally, the increasing focus on early detection and management of respiratory diseases augments the need for accurate diagnostic tools in hospital settings. Moreover, technological advancements and the integration of spirometers into hospital information systems further drive the growth of this segment.

Region with largest share:

North America is set to secure the largest market share in the spirometers market owing to its advanced healthcare infrastructure, high healthcare expenditure and robust focus on respiratory health. Additionally, increased awareness, favorable reimbursement policies and technological advancements in spirometry devices contribute to the market's growth. Furthermore, a high prevalence of respiratory diseases and a proactive approach to healthcare innovation in North America position the region as a key market leader, with a significant share in the adoption and implementation of spirometry solutions.

Region with highest CAGR:

Asia Pacific is poised to register robust growth in the spirometers market owing to the region's rising prevalence of respiratory disorders coupled with a growing geriatric population. Additionally, increasing healthcare expenditure, improving healthcare infrastructure and a surge in awareness regarding respiratory health further drive the market. Moreover, technological advancements, the adoption of portable and affordable spirometry devices and the expansion of healthcare access to rural areas foster the market's growth in the Asia Pacific region.

Key players in the market:

Some of the key players in spirometers market include Benson Medical Instruments, Bionet America, Inc., CareFusion, Cosmed Srl, Fukuda Sangyo Co., Ltd., Future Med Devices Pvt. Ltd., Medikro Oy, MGC Diagnostics Corporation, Midmark Corporation, Morgan Scientific Inc., NDD Medical Technologies, Nihon Kohden Corporation, Schiller AG, SDI Diagnostics, Vitalograph Ltd and Welch Allyn, Inc.

Key Developments:

In September 2023, Alveofit (Roundworks Technologies) has received approval from the US Food and Drug Administration (FDA) for its portable digital spirometer, alveoair. With this approval, the company plans to start distributing the product in the US.

In January 2023, Koneksa, a healthcare technology company developing evidence-based validated digital biomarkers, today announced the launch of a clinical study comparing the treatment effect between at-home mobile spirometry using digital biomarkers and in-clinic spirometry in patients with moderate asthma on long-acting beta-agonist (LABA) treatment.

In September 2022, RxCap, Inc. collaborated with ZEPHYRx to connect the ZEPHYRx online spirometry platform to RxCap's remote surveillance platform. RxCap's corporate customers, who include providers and payers, may now track the lung health of their clients and patients who have severe respiratory diseases.

Products Covered:

• Devices
• Software
• Consumables & Accessories

Technologies Covered:

• Volume Measurement
• Flow Measurement

Applications Covered:

• Chronic Obstructive Pulmonary Disease (COPD)
• Asthma
• Cystic Fibrosis
• Pulmonary Fibrosis
• Other Applications

End Users Covered:

• Hospitals
• Clinics
• Homecare

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Technology Analysis
• 3.8 Application Analysis
• 3.9 End User Analysis
• 3.10 Emerging Markets
• 3.11 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Spirometers Market, By Product

• 5.1 Introduction
• 5.2 Devices
  • 5.2.1 Desktop Spirometer
  • 5.2.2 Hand Held Spirometer
  • 5.2.3 Table Top Spirometer
• 5.3 Software
• 5.4 Consumables & Accessories

6 Global Spirometers Market, By Technology

• 6.1 Introduction
• 6.2 Volume Measurement
• 6.3 Flow Measurement

7 Global Spirometers Market, By Application

• 7.1 Introduction
• 7.2 Chronic Obstructive Pulmonary Disease (COPD)
• 7.3 Asthma
• 7.4 Cystic Fibrosis
• 7.5 Pulmonary Fibrosis
• 7.6 Other Applications

8 Global Spirometers Market, By End User

• 8.1 Introduction
• 8.2 Hospitals
• 8.3 Clinics
• 8.4 Homecare

9 Global Spirometers Market, By Geography

• 9.1 Introduction
• 9.2 North America
  • 9.2.1 US
  • 9.2.2 Canada
  • 9.2.3 Mexico
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 Italy
  • 9.3.4 France
  • 9.3.5 Spain
  • 9.3.6 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 New Zealand
  • 9.4.6 South Korea
  • 9.4.7 Rest of Asia Pacific
• 9.5 South America
  • 9.5.1 Argentina
  • 9.5.2 Brazil
  • 9.5.3 Chile
  • 9.5.4 Rest of South America
• 9.6 Middle East & Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 UAE
  • 9.6.3 Qatar
  • 9.6.4 South Africa
  • 9.6.5 Rest of Middle East & Africa

10 Key Developments

• 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 10.2 Acquisitions & Mergers
• 10.3 New Product Launch
• 10.4 Expansions
• 10.5 Other Key Strategies

11 Company Profiling

• 11.1 Benson Medical Instruments
• 11.2 Bionet America, Inc.
• 11.3 CareFusion
• 11.4 Cosmed Srl
• 11.5 Fukuda Sangyo Co., Ltd.
• 11.6 Future Med Devices Pvt. Ltd.
• 11.7 Medikro Oy
• 11.8 MGC Diagnostics Corporation
• 11.9 Midmark Corporation
• 11.10 Morgan Scientific Inc.
• 11.11 NDD Medical Technologies
• 11.12 Nihon Kohden Corporation
• 11.13 Schiller AG
• 11.14 SDI Diagnostics
• 11.15 Vitalograph Ltd
• 11.16 Welch Allyn, Inc.